GAAP net income of $179 million, or $0.51 per share
Non-GAAP net income of $222 million, or $0.63 per share(1)
Orders of $1.71 billion, up 5 percent over a year ago. Revenues of $1.68 billion, up 3 percent from one year ago
Second-quarter fiscal year 2013 revenue guidance of $1.74 billion to $1.77 billion and non-GAAP earnings guidance of $0.64 to $0.70 per share(2)
Fiscal year 2013 revenue guidance of $6.9 billion to $7.1 billion. Non-GAAP earnings guidance at $2.70 to $3.00 per share(2)
SANTA CLARA, Calif., Feb. 14, 2013
Agilent Technologies Inc. (NYSE: A) today reported revenues of $1.68 billion for the first fiscal quarter ended Jan. 31, 2013, 3 percent above one year ago. First-quarter GAAP net income was $179 million, or $0.51 per share. Last year's first-quarter GAAP net income was $230 million, or $0.65 per share.
During the first quarter, Agilent had intangible amortization of $52 million and acquisition, integration and transformation costs of $13 million. The company also recognized a tax benefit of $27 million. Excluding these items and $5 million of other net charges, Agilent reported first-quarter adjusted net income of $222 million, or $0.63 per share(1).
Agilent CEO Bill Sullivan said, "While we currently face some volatility in our end-markets, we remain excited by our long-term prospects, including opportunities in emerging markets. Agilent will continue to invest in R&D to ensure that we maintain the cutting-edge products and technology leadership that our customers expect from us."
Electronic Measurement first-quarter revenues declined 7 percent compared with the prior year, primarily due to an anticipated decrease in the communications market. Operating margins were 17 percent.
Chemical Analysis revenues were down 1 percent compared with a year ago, driven by soft environmental markets. Operating margins were 21 percent.
Life Sciences revenues were up 2 percent over a year ago. Pharma saw modest growth, while academic/government markets were flat. Operating margins were 15 percent.
Diagnostics and Genomics grew 145 percent, 4 percent excluding the effects of the Dako acquisition. Operating margins were 13 percent.
Agilent generated $245 million of cash from operations in the quarter. First-quarter ROIC was 14 percent(3).
Second-quarter 2013 revenues are expected to be in the range of $1.74 billion to $1.77 billion. Second-quarter non-GAAP earnings are expected to be in the range of $0.64 to $0.70 per share(2).
For the full fiscal year 2013, Agilent now expects revenue of $6.9 billion to $7.1 billion and non-GAAP earnings of $2.70 to $3.00 per share(2).